Eli Lilly and Company

Company LLY

Last mentioned: 16h ago

Key Data

ticker
LLY
name
Eli Lilly and Company
price
900
change
15
changePct
1.69

Timeline

  1. Off-Label Drug Mandate

    The Vida Health nurse insists Davis try generic naltrexone and bupropion (unapproved for sleep apnea) before approving Zepbound, leading him to abandon the process.

  2. Vida Health Assessment

    Davis completes blood work, health questionnaires, and multiple video visits with a Vida Health nurse.

  3. Employer Imposes Vida Health Requirement

    Before filling the prescription, Davis's employer adds a mandatory program with telehealth company Vida Health to manage obesity drug benefits.

  4. Zepbound Prescription Issued

    David Davis receives a prescription for Zepbound from his primary care doctor to treat obstructive sleep apnea.

Stories mentioning Eli Lilly and Company 1

About Eli Lilly and Company coverage

This page surfaces every story mentioning Eli Lilly and Company across our startup coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running startup beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where Eli Lilly and Company was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.